|
Shukra Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
2240.19 Cr.
|
P/BV
|
41.27
|
Book Value (Rs.)
|
1.24
|
|
52 Week High/Low (Rs.)
|
51/7
|
FV/ML
|
1/1
|
P/E(X)
|
234.03
|
|
Bookclosure
|
18/09/2025
|
EPS (Rs.)
|
0.22
|
Div Yield (%)
|
0.02
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.22 | 16.93 | 26.21 | 4.79 | 0.22 |
| Diluted EPS (Rs.) | 0.22 | 16.93 | 26.21 | 4.79 | 0.22 |
| Cash EPS (Rs.) | 0.28 | 18.81 | 15.95 | 15.41 | 9.63 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.44 | 52.65 | 64.63 | 104.43 | 99.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.44 | 52.65 | 64.63 | 104.43 | 99.63 |
| Dividend / Share (Rs.) | 0.01 | 1.00 | 0.50 | 0.50 | 0.00 |
| Revenue From Operations / Share (Rs.) | 0.74 | 68.12 | 150.31 | 130.84 | 71.51 |
| PBDIT / Share (Rs.) | 0.38 | 20.30 | 16.76 | 18.95 | 11.50 |
| PBIT / Share (Rs.) | 0.31 | 18.42 | 12.07 | 8.33 | 2.09 |
| PBT / Share (Rs.) | 0.30 | 18.16 | 11.35 | 6.50 | 0.62 |
| Net Profit / Share (Rs.) | 0.21 | 16.93 | 11.26 | 4.79 | 0.21 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 51.97 | 29.79 | 11.15 | 14.48 | 16.07 |
| PBIT Margin (%) | 42.75 | 27.04 | 8.02 | 6.36 | 2.91 |
| PBT Margin (%) | 40.92 | 26.66 | 7.54 | 4.96 | 0.87 |
| Net Profit Margin (%) | 29.38 | 24.85 | 7.48 | 3.66 | 0.30 |
| Return on Networth / Equity (%) | 15.23 | 32.16 | 17.41 | 4.59 | 0.21 |
| Return on Capital Employeed (%) | 20.04 | 31.66 | 14.54 | 5.73 | 1.14 |
| Return On Assets (%) | 11.03 | 23.81 | 5.87 | 2.13 | 0.09 |
| Long Term Debt / Equity (X) | 0.04 | 0.04 | 0.14 | 0.19 | 0.62 |
| Total Debt / Equity (X) | 0.06 | 0.05 | 0.20 | 0.20 | 0.62 |
| Asset Turnover Ratio (%) | 0.39 | 0.97 | 1.07 | 0.58 | 0.32 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.79 | 3.97 | 1.25 | 1.27 | 2.46 |
| Quick Ratio (X) | 3.21 | 3.81 | 1.17 | 0.94 | 2.19 |
| Inventory Turnover Ratio (X) | 5.31 | 4.89 | 3.19 | 3.93 | 1.93 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.37 | 1.77 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.34 | 1.25 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 99.63 | 98.23 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 99.66 | 98.75 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 28.47 | 77.96 | 23.36 | 10.35 | 54.07 |
| Interest Coverage Ratio (Post Tax) (%) | 17.10 | 66.04 | 16.69 | 3.62 | 7.88 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 948.82 | 350.65 | 19.48 | 12.75 | 16.23 |
| EV / Net Operating Revenue (X) | 29.12 | 4.70 | 0.33 | 0.62 | 1.45 |
| EV / EBITDA (X) | 56.02 | 15.78 | 2.97 | 4.30 | 9.02 |
| MarketCap / Net Operating Revenue (X) | 29.36 | 4.79 | 0.31 | 0.46 | 0.62 |
| Retention Ratios (%) | 0.00 | 99.62 | 98.22 | 0.00 | 0.00 |
| Price / BV (X) | 15.23 | 6.20 | 0.72 | 0.57 | 0.44 |
| Price / Net Operating Revenue (X) | 29.36 | 4.79 | 0.31 | 0.46 | 0.62 |
| EarningsYield | 0.01 | 0.05 | 0.23 | 0.07 | 0.00 |
